Soleno Therapeutics Inc (SLNO)

Investing Cash Flow

-$186.74M

TTM · Period ending: · USD

SLNO logo

SLNO Investing Cash Flow

Latest reported-$186.74M
SLNO TTM Cash from Investing (-$1.27K → -$186.74M)
High-resolution chart · PNG

SLNO investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Soleno Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-186,735,000
-201,781,000
-69,978,000
25,505,000
-87,501,000
-225,682,000
-232,125,000
-236,165,000
-115,244,000
0
-6,000
-13,000
-20,000
-20,000
-27,000
-25,000
-18,000
-22,000
-13,000
-11,000
-11,000
-7,000
100,000
544,000
538,000
528,000
251,000
-195,000
-190,000
-180,000
233,782
609,782
382,782
378,782
139,320
-231,680
-23,680
-38,680
-70,777
-1,328,777
-1,338,777
-1,320,777
-1,319,683
-57,609
-31,683
-26,683
3,726
-1,348
4,000
-1,274
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.